×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CRDL – cardiol therapeutics inc. - class a common shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CRDL
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/15
06:26 am
crdl
Cardiol Therapeutics CEO: Phase III MAVERIC Nears Full Enrollment as CardiolRx Shows Myocarditis Promise [Yahoo! Finance]
Low
Report
Cardiol Therapeutics CEO: Phase III MAVERIC Nears Full Enrollment as CardiolRx Shows Myocarditis Promise [Yahoo! Finance]
4/14
08:07 pm
crdl
Cardiol Therapeutics to Highlight MAVERIC Phase III Trial and Recently Published ARCHER Results in Live Interview with Barchart [Yahoo! Finance]
Low
Report
Cardiol Therapeutics to Highlight MAVERIC Phase III Trial and Recently Published ARCHER Results in Live Interview with Barchart [Yahoo! Finance]
4/6
11:25 am
crdl
Cardiol Therapeutics (CRDL) had its "buy" rating reaffirmed by Canaccord Genuity Group Inc.. They now have a $8.00 price target on the stock.
Low
Report
Cardiol Therapeutics (CRDL) had its "buy" rating reaffirmed by Canaccord Genuity Group Inc.. They now have a $8.00 price target on the stock.
4/5
01:06 am
crdl
Cardiol Therapeutics (CRDL) was upgraded by Wall Street Zen from "sel
Low
Report
Cardiol Therapeutics (CRDL) was upgraded by Wall Street Zen from "sel
3/8
08:03 pm
crdl
Cardiol Therapeutics Touts Phase III MAVERIC Timeline for CardiolRx at TD Cowen Healthcare Conference [Yahoo! Finance]
Low
Report
Cardiol Therapeutics Touts Phase III MAVERIC Timeline for CardiolRx at TD Cowen Healthcare Conference [Yahoo! Finance]
2/25
07:42 am
crdl
Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
Low
Report
Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
2/10
01:32 pm
crdl
Cardiol Therapeutics (NASDAQ:CRDL) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Low
Report
Cardiol Therapeutics (NASDAQ:CRDL) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
2/6
05:33 pm
crdl
Cardiol Therapeutics (NASDAQ:CRDL) was upgraded by analysts at Brookline Cap M to a "strong-buy" rating.
Medium
Report
Cardiol Therapeutics (NASDAQ:CRDL) was upgraded by analysts at Brookline Cap M to a "strong-buy" rating.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
4/14
07:30 am
crdl
Form 6-K Cardiol Therapeutics For: Apr 14
Low
Report
Form 6-K Cardiol Therapeutics For: Apr 14
4/10
01:13 pm
crdl
Form 6-K Cardiol Therapeutics For: Apr 10
Low
Report
Form 6-K Cardiol Therapeutics For: Apr 10
4/1
07:30 am
crdl
Form 6-K Cardiol Therapeutics For: Apr 01
Low
Report
Form 6-K Cardiol Therapeutics For: Apr 01
3/31
04:48 pm
crdl
Form 40-F Cardiol Therapeutics For: Dec 31
High
Report
Form 40-F Cardiol Therapeutics For: Dec 31
2/25
07:40 am
crdl
Form 6-K Cardiol Therapeutics For: Feb 25
Low
Report
Form 6-K Cardiol Therapeutics For: Feb 25
2/10
07:33 am
crdl
Form 6-K Cardiol Therapeutics For: Feb 10
Medium
Report
Form 6-K Cardiol Therapeutics For: Feb 10
2/2
04:01 pm
crdl
Form 6-K Cardiol Therapeutics For: Jan 23
Medium
Report
Form 6-K Cardiol Therapeutics For: Jan 23
1/30
04:01 pm
crdl
Form SCHEDULE 13G Cardiol Therapeutics Filed by: MMCAP International Inc. SPC
Low
Report
Form SCHEDULE 13G Cardiol Therapeutics Filed by: MMCAP International Inc. SPC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: